These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31730586)

  • 1. Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 5(2):1-19. PubMed ID: 31730586
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress.
    Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 14(9):1-24. PubMed ID: 33843880
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 14(9):20-23. PubMed ID: 33843881
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting: Commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 5(2):16-19. PubMed ID: 31730587
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):1-24. PubMed ID: 33843919
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):18-22. PubMed ID: 33843920
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):1-24. PubMed ID: 33843865
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent Advances in the Treatment of MDS. A review of selected presentations from the 48th Annual Meeting of the American Society of Hematology, December 9-12, 2006, Orlando, Florida.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 6):1-13; quiz 15-6. PubMed ID: 17519888
    [No Abstract]   [Full Text] [Related]  

  • 10. MDS researchers seek treatments but find few.
    Bankhead C
    J Natl Cancer Inst; 2007 Jul; 99(13):996-7. PubMed ID: 17596568
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the treatment of myelodysplastic syndromes.
    Clin Adv Hematol Oncol; 2008 Mar; 6(3 Suppl 6):1-13; discussion 14; quiz 15-6. PubMed ID: 18391911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and New Treatment for Myelodysplastic Syndromes].
    Miyazaki Y
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1974-9. PubMed ID: 30160908
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification, treatment goals, and management principles for myelodysplastic syndromes.
    Gore S
    Cancer Control; 2004; 11(6 Suppl):3-6. PubMed ID: 15625530
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction to a review series on myelodysplastic syndromes.
    Löwenberg B
    Blood; 2019 Mar; 133(10):1001. PubMed ID: 30670447
    [No Abstract]   [Full Text] [Related]  

  • 15. Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials.
    Mo A; McQuilten ZK; Wood EM; Weinkove R
    Intern Med J; 2017 Jun; 47(6):695-698. PubMed ID: 28580745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting report: myelodysplastic syndromes at ASH 2007.
    Itzykson R; Gardin C; Fenaux P
    Leukemia; 2008 May; 22(5):893-7. PubMed ID: 18323798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental gains and a long road ahead in MDS.
    Steensma DP; Tefferi A
    Oncology (Williston Park); 2008 Nov; 22(12):1352, 1358, 1360. PubMed ID: 19320067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myelodysplastic syndromes (MDS) in children].
    Chybicka A
    Pol Arch Med Wewn; 1998 Feb; 99(2):137-43. PubMed ID: 9686515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myelodysplastic syndrome, a guide for clinical practice].
    Suzuki T
    Rinsho Ketsueki; 2013 Oct; 54(10):1671-81. PubMed ID: 24064816
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent frustration and innovation in myelodysplastic syndrome.
    Platzbecker U; Fenaux P
    Haematologica; 2016 Aug; 101(8):891-3. PubMed ID: 27478197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.